Dr. Freeman Hwang

Dr. Julianna Czum’s primary focus is cardiothoracic imaging, with clinical subspecialties in noninvasive cardiovascular and thoracic imaging. Dr. Czum earned her medical degree from UMDNJ - Robert Wood Johnson Medical School before going on to an internship at Mary Imogene Bassett Hospital and residency at St. Barnabas Medical Center. She completed a fellowship in cardiovascular magnetic resonance in a combined Henry Jackson Foundation-funded program at the National Institutes of Health, National Naval Medical Center and Uniformed Services University of the Health Sciences. Dr. Czum joined the diagnostic faculty in June 2022. Dr. Czum is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Pleurisy, ALK-Positive Non-Small Cell Lung Cancer, Chronic Cough, and Lung Nodules.

Maya Galperin is a Radiologist in Philadelphia, Pennsylvania. Dr. Galperin is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Emphysema, Pleurisy, Pleural Effusion, and Lung Nodules.

Dr. Linda Chi Hang Chu is an Associate Professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science. Her clinical expertise includes body CT, MRI and US. Her research interests include abdominal imaging, cancer imaging, radiomics, and artificial intelligence. Dr. Chu graduated from the University of Toronto in 2003 and was awarded the Governor General's Silver Medal, the highest academic achievement from the undergraduate program. She earned her medical degree as a member of AOA and phi beta kappa from Johns Hopkins University in Baltimore, MD in 2007. She completed her Diagnostic Radiology residency and body MRI fellowship at Johns Hopkins Hospital. Dr. Chu joined the Johns Hopkins faculty in 2013. Dr. Chu is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Pancreatic Ductal Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, Muscle Invasive Bladder Cancer, Pancreaticoduodenectomy, and Gallbladder Removal.